Evidence map›Paper›PMID 23388006›Full record

ReviewThe New England journal of medicine2013

Designing tomorrow's vaccines.

Gary J Nabel

Abstract readHistorical ArticleReview
In one paragraph

Review in The New England journal of medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 129 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
129citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

129 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Controlling timing and location in vaccines.Advanced drug delivery reviews · 2020
    Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Glycan-costumed virus-like particles promote type 1 anti-tumor immunity.bioRxiv : the preprint server for biology · 2024
    Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Designing an inclusive immunization schedule for children and adults in India.Therapeutic advances in vaccines and immunotherapy · 2023
    Article

69 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Gary J NabelVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. gary.nabel@sanofi.com

Funding

Influenza Vaccine Research and DevelopmentZIAAI005003 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI KANEKIYO, MASARU · 2009 to 2025
$89.8M
HIV/AIDS Vaccine DevelopmentZIAAI005002 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI MASCOLA, JOHN · 2009 to 2018
$50.9M
Mechanisms Of HIV-1 Induced Cell Death and Latency Formation in CD4+ LymphocytesZIAAI005058 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI MASCOLA, JOHN · 2009 to 2018
$3.7M
HIV/AIDS Vaccine DevelopmentZ01AI005002 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI NABEL, GARY J · 2002 to 2008
$3.5M
Influenza Vaccine DevelopmentZ01AI005003 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI NABEL, GARY J · 2002 to 2008
$2.7M
Intramural NIH HHS Z01 AI005002Intramural NIH HHS Z01 AI005003Intramural NIH HHS Z99 AI999999Intramural NIH HHS ZIA AI005002Intramural NIH HHS ZIA AI005003Intramural NIH HHS ZIA AI005058NIAID NIH HHS Y99 AI999999
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Communicable Disease ControlDrug DesignVaccinesAllergy and ImmunologyAntibodies, NeutralizingClinical Trials as TopicCommunicable DiseasesDendritic CellsEvolution, MolecularHistory, 19th CenturyHistory, 20th CenturyHistory, 21st CenturyHost-Pathogen InteractionsHumansLicensureTranslational Research, BiomedicalAntibodies, NeutralizingVaccines

Identifiers

PMID23388006
PMCPMC3612922

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.